No­var­tis re­port­ed­ly in talks to buy Mor­phoSys; Astel­las cuts PhII pro­gram; Si­lence's $120M pri­vate place­ment

Plus, news about Ad­verum, Bridge­Bio Phar­ma, Vax­cyte, Cor­bus and Im­muno­core:

No­var­tis re­port­ed­ly in deal talks with Mor­phoSys: The Swiss Big Phar­ma is in ad­vanced talks …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER